Shareholders Win Cert. In Suit Over Matrixx Cold Medicine

Law360, New York (February 27, 2012, 4:41 PM EST) -- A group of shareholders won class certification Monday in an 8-year-old Arizona suit alleging Matrixx Initiatives Inc. violated securities laws by concealing reports that cold medication Zicam caused a potentially permanent loss of the sense of smell.

U.S. District Judge Neil V. Wake certified a class of all people and entities who were damaged by their purchases of publicly traded Matrixx securities between Oct. 22, 2003, and Feb. 6, 2004, in a case that traveled all the way up to the U.S. Supreme Court before eventually...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.